NEW YORK (BUSINESS WIRE) Kallyope, Inc., a leading biotechnology company focused on identifying and developing therapeutics involving the gut-brain axis, today announced the formation of its inaugural Clinical Development Advisory Board. The board is composed of four distinguished physicians and scientists who wil.
Renowned Biopharma Leaders Join Newly Established Kallyope Clinical Development Advisory Board - read this article along with other careers information, tips and advice on BioSpace